A potential role for daptomycin in enterococcal infections: what is the evidence?-authors' response

被引:1
作者
Canton, Rafael [1 ,2 ,3 ]
Ruiz-Garbajosa, Patricia [1 ,2 ,3 ]
Chaves, Ricardo L. [4 ]
Johnson, Alan P. [5 ]
机构
[1] Hosp Univ Ramon & Cajal, Microbiol Serv, Madrid, Spain
[2] IRYCIS, Madrid, Spain
[3] CIBERESP, Madrid, Spain
[4] Novartis Pharma AG, CH-4056 Basel, Switzerland
[5] Hlth Protect Agcy Ctr Infect, Dept Healthcare Associated Infect & Antimicrobial, London NW9 5EQ, England
关键词
Enterococcus; chronic prostatitis; biofilms; VANCOMYCIN;
D O I
10.1093/jac/dkr051
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1196 / 1197
页数:3
相关论文
共 12 条
  • [1] Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence?
    Cai, Tommaso
    Mazzoli, Sandra
    Malossini, Gianni
    Bartoletti, Riccardo
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (05) : 1195 - 1196
  • [2] A potential role for daptomycin in enterococcal infections: what is the evidence?
    Canton, Rafael
    Ruiz-Garbajosa, Patricia
    Chaves, Ricardo L.
    Johnson, Alan P.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) : 1126 - 1136
  • [3] INVITRO PHARMACODYNAMIC EFFECTS OF CONCENTRATION, PH, AND GROWTH-PHASE ON SERUM BACTERICIDAL ACTIVITIES OF DAPTOMYCIN AND VANCOMYCIN
    LAMP, KC
    RYBAK, MJ
    BAILEY, EM
    KAATZ, GW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) : 2709 - 2714
  • [4] Treatment of Bacterial Prostatitis
    Lipsky, Benjamin A.
    Byren, Ivor
    Hoey, Christopher T.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (12) : 1641 - 1652
  • [5] Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications
    Mazzoli, Sandra
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2010, 59 (03): : 337 - 344
  • [6] Mazzoli Sandra, 2007, Arch Ital Urol Androl, V79, P71
  • [7] Biofilm formation by enterococci
    Mohamed, Jamal A.
    Huang, David B.
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (12) : 1581 - 1588
  • [8] Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis
    Naber, K. G.
    Roscher, K.
    Botto, H.
    Schaefer, V.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (02) : 145 - 153
  • [9] Linezolid - A review of its use in the management of serious Gram-positive infections
    Perry, CM
    Jarvis, B
    [J]. DRUGS, 2001, 61 (04) : 525 - 551
  • [10] Vancomycin-resistant Enterococcus faecium:: Catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm
    Raad, II
    Hanna, HA
    Boktour, M
    Chaiban, G
    Hachem, RY
    Dvorak, T
    Lewis, R
    Murray, BE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) : 5046 - 5050